Shearman & Sterling is advising Hong Kong-listed Golden Meditech, a leading integrated healthcare company engaged in the development, manufacture, sales and distribution of blood-related medical devices…
Golden Meditech’s $830 Million Sale of Stake in China Cord Blood
![](https://globallegalchronicle.com/wp-content/uploads/2017/03/9438ef02c6.jpeg)